NM_020461.4:c.5285C>T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_020461.4(TUBGCP6):​c.5285C>T​(p.Pro1762Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000213 in 1,611,854 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. P1762P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00024 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00021 ( 3 hom. )

Consequence

TUBGCP6
NM_020461.4 missense

Scores

3
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 2.26

Publications

6 publications found
Variant links:
Genes affected
TUBGCP6 (HGNC:18127): (tubulin gamma complex component 6) The protein encoded by this gene is part of a large multisubunit complex required for microtubule nucleation at the centrosome. [provided by RefSeq, Jul 2008]
TUBGCP6 Gene-Disease associations (from GenCC):
  • microcephaly and chorioretinopathy 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003908932).
BP6
Variant 22-50218001-G-A is Benign according to our data. Variant chr22-50218001-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 212516.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000243 (37/152220) while in subpopulation EAS AF = 0.00543 (28/5152). AF 95% confidence interval is 0.00386. There are 0 homozygotes in GnomAd4. There are 22 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TUBGCP6NM_020461.4 linkc.5285C>T p.Pro1762Leu missense_variant Exon 24 of 25 ENST00000248846.10 NP_065194.3 Q96RT7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TUBGCP6ENST00000248846.10 linkc.5285C>T p.Pro1762Leu missense_variant Exon 24 of 25 1 NM_020461.4 ENSP00000248846.5 Q96RT7-1

Frequencies

GnomAD3 genomes
AF:
0.000243
AC:
37
AN:
152102
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00542
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000562
AC:
138
AN:
245762
AF XY:
0.000544
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000292
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00615
Gnomad FIN exome
AF:
0.000234
Gnomad NFE exome
AF:
0.000163
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000210
AC:
306
AN:
1459634
Hom.:
3
Cov.:
36
AF XY:
0.000172
AC XY:
125
AN XY:
726214
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33332
American (AMR)
AF:
0.0000225
AC:
1
AN:
44424
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26094
East Asian (EAS)
AF:
0.00398
AC:
158
AN:
39694
South Asian (SAS)
AF:
0.000104
AC:
9
AN:
86178
European-Finnish (FIN)
AF:
0.000114
AC:
6
AN:
52562
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5758
European-Non Finnish (NFE)
AF:
0.0000666
AC:
74
AN:
1111294
Other (OTH)
AF:
0.000929
AC:
56
AN:
60298
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
26
52
77
103
129
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000243
AC:
37
AN:
152220
Hom.:
0
Cov.:
33
AF XY:
0.000296
AC XY:
22
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41558
American (AMR)
AF:
0.00
AC:
0
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00543
AC:
28
AN:
5152
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
67972
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000128
Hom.:
0
Bravo
AF:
0.000393
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000120
AC:
1
ExAC
AF:
0.000505
AC:
61
Asia WGS
AF:
0.00433
AC:
15
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.000296

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TUBGCP6: BP4 -

not specified Uncertain:1
Feb 19, 2015
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Microcephaly and chorioretinopathy 1 Benign:1
Sep 13, 2018
Knight Diagnostic Laboratories, Oregon Health and Sciences University
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
20
DANN
Uncertain
1.0
DEOGEN2
Benign
0.18
T;.
Eigen
Benign
-0.087
Eigen_PC
Benign
-0.069
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Benign
0.78
T;T
M_CAP
Benign
0.010
T
MetaRNN
Benign
0.0039
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N;.
PhyloP100
2.3
PrimateAI
Benign
0.43
T
PROVEAN
Uncertain
-4.2
D;D
REVEL
Benign
0.11
Sift
Benign
0.053
T;D
Sift4G
Benign
0.078
T;T
Polyphen
0.99
D;.
Vest4
0.54
MVP
0.46
MPC
0.39
ClinPred
0.13
T
GERP RS
3.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.085
gMVP
0.41
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201721812; hg19: chr22-50656430; COSMIC: COSV107216554; COSMIC: COSV107216554; API